HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Hospitals’ COVID-19 Treatment Protocols Aren’t Prescriptions To Make Vitamin C Ad Claims

Executive Summary

Marketer of Billy’s Infinity-C supplement line discontinues social media post that COVID-19 patients in hospitals are receiving high doses of vitamin C. BBB National Programs division says the post implies consumers can prevent contracting the virus through vitamin C use. 

You may also be interested in...



DAB Defense Sanitizer Firm Washes Hands Of ‘Bacteria-Resistant Glove’ Claim Without Argument

Three Kings discontinued dozens of claims for DAB Defense Against Bacteria Hand Sanitizer + Protectant following S.C. Johnson challenge in a National Advertising Division review.

COVID-19 Claims In Instagram By OTC IV Provider

After challenging claims made in Instagram post and advised business offering walk-in and by-appointment services at multiple NYC locations, NAD referred its questions to regulators after the firm failed to provide substantiation.

COVID-19 Claims for OTC Intravenous Drips Found In Advertising On Both Sides Of Atlantic

UK agency advises two medical spas to discontinue claims suggesting IV drips prevent or cure COVID-19. In separate rulings to the companies, ASA notes the UK MHRA says including COVID-19 in promotions would bring the IV drips under medicines regulation.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel